Literature DB >> 6644315

CSF and plasma vasopressin concentrations in dementia.

P S Sørensen, M Hammer, S Vorstrup, F Gjerris.   

Abstract

In 16 patients with primary degenerative dementia mean CSF vasopressin concentration was lower (0.9 +/- 0.1 pg/ml (mean +/- SEM)) than in 28 control patients (1.3 +/- 0.1 (mean +/- SEM)) (p less than 0.01). In 18 patients with normal pressure hydrocephalus and potentially reversible dementia mean CSF vasopressin concentration (1.2 pg/ml +/- 0.1 (mean +/- SEM)) was not different from that found in controls. Several of the demented patients had inappropriate plasma vasopressin concentrations suggesting a defect in osmoregulation. These findings encourage further clinical trials of vasopressin in patients with primary degenerative dementia, but it is emphasised that the low CSF vasopressin concentration in these patients might be only a nonspecific phenomenon due to the diffuse loss of cells within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644315      PMCID: PMC1027604          DOI: 10.1136/jnnp.46.10.911

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia.

Authors:  M N Rossor; L L Iversen; C Q Mountjoy; M Roth; J Hawthorn; V Y Ang; J S Jenkins
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

2.  Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis.

Authors:  M D Penney; D Murphy; G Walters
Journal:  Br Med J       Date:  1979-12-08

3.  Influence of vasopressin on learning and memory.

Authors:  J J Legros; P Gilot; X Seron; J Claessens; A Adam; J M Moeglen; A Audibert; P Berchier
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

4.  Vasopressin in amnesia.

Authors:  J C Oliveros; M K Jandali; M Timsit-Berthier; R Remy; A Benghezal; A Audibert; J M Moeglen
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Extrahypothalamic vasopressin in human brain.

Authors:  M N Rossor; L L Iversen; J Hawthorn; V T Ang; J S Jenkins
Journal:  Brain Res       Date:  1981-06-15       Impact factor: 3.252

6.  Effects of vasopressin on human memory functions.

Authors:  H Weingartner; P Gold; J C Ballenger; S A Smallberg; R Summers; D R Rubinow; R M Post; F K Goodwin
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

7.  Hypothalamus and dementia.

Authors:  D M Mann; P O Yates; D V Bansal; D J Marshall
Journal:  Lancet       Date:  1981-02-14       Impact factor: 79.321

8.  Radioimmunoassay of 8-arginine-vasopressin (antidiuretic hormone) in human plasma.

Authors:  M Hammer
Journal:  Scand J Clin Lab Invest       Date:  1978-12       Impact factor: 1.713

9.  Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage.

Authors:  H M Mather; V Ang; J S Jenkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

10.  Antidiuretic hormone levels in stroke patients.

Authors:  R J Joynt; J H Feibel; C M Sladek
Journal:  Ann Neurol       Date:  1981-02       Impact factor: 10.422

View more
  3 in total

1.  Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

Authors:  K Fujiyoshi; H Suga; K Okamoto; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

2.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

3.  Neuroprotective effect of total glycosides from paeonies against neurotoxicity induced by strychnos alkaloids related to recovering the levels of neurotransmitters and neuroendocrine hormones in rat serum and brain.

Authors:  Linjia Sun; Yu Chen; Chenzhi Hou; Xiaoyang Sun; Zhipeng Wang; Shujuan Li; Mingming Lv; Xiaohui Chen
Journal:  RSC Adv       Date:  2018-08-16       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.